Zdrowie i gospodarka · 19/12/2023

FDA Clears MEPHYTON Tablets for Sale, Citing Lack of Safety or Effectiveness Concerns

The US Food and Drug Administration (FDA) has ruled that MEPHYTON (phytonadione) tablets, 5 milligrams, were not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications (ANDAs) for the product.